top of page

RESEARCH

PUBLICATIONS

GNB1 Publications

2026

  • Expert comment for "Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene"

de Carvalho Aguiar P. Expert comment for "Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene". Parkinsonism Relat Disord. 2026;147:108338. doi:10.1016/j.parkreldis.2026.108338

https://pubmed.ncbi.nlm.nih.gov/42067479/#full-view-affiliation-1​​​

  • GIRK Channel Loss of Function Increases Dendritic Excitability in a Mouse Model of GNB1 Encephalopathy

Gritz S, Voleti A, Scarnati MS, Galloni AR, Milstein AD. Girk channel loss of function increases dendritic excitability in a mouse model of GNB1 encephalopathy. bioRxiv. 2026; doi:10.64898/2026.08.08.743706. https://www.biorxiv.org/content/10.64898/2026.08.08.743706v1.full

  • Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene

Street D, Teare L, Georgieva T, et al. Myoclonus-dystonia due to novel mutation in the guanine nucleotide-binding protein (GNB1) gene. Parkinsonism Relat Disord. 2026;147:107822. doi:10.1016/j.parkreldis.2025.107822

‌https://pubmed.ncbi.nlm.nih.gov/40210557/

​​​

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2016

G-protein Publications

2026

  • Cross-species analysis of GNB1 I80T encephalopathy: conserved developmental, epileptic and neuronal transcriptome signatures​

​Reddy HP, Ranjan V, Klo M, Shapiro G, Bassan H, Harel G, Heimer G, Ben Zeev B, Rabinski T, Vatine GD, Yaffe Y. Cross-species analysis of GNB1 I80T encephalopathy: conserved developmental, epileptic and neuronal transcriptome signatures. bioRxiv. 2026;2026-08. doi:https://doi.org/10.64898/2026.08.03.742477.

https://www.biorxiv.org/content/10.64898/2026.08.03.742477v1

​​​​

2025

2023

2022

2021

2020

2006

Therapies and Drug-related

2025

  • Hit identification for membrane protein drug discovery

Rawlins P. Hit identification for membrane protein drug discovery. Drug Target Review. 2025. 

https://www.drugtargetreview.com/article/158267/advancements-in-hit-identification-for-membrane-protein-drug-discovery/ 

2023

2013

2012

Thanks for submitting!

The GNB1 Advocacy Group is a 501(c)(3) public charity. Our tax identification number is 99-1719087.

© 2025 GNB1 Advocacy

bottom of page